AIM: To investigate the effect of Astragalus-Angelica combination on cell injury in the vascular wall of mouse atherosclerosis (AS) model from perspectives of cell apoptosis and pyroptosis. METHODS: Male apolipoprotein E gene knockout (ApoE~f~) mice were randomly divided into model group, low-dose Astragalus-Angelica group, me-dium-dose Astragalus-Angelica group, high-dose Astragalus-Angelica group and atorvastatin group, with 5 mice in each group. The same number of male C57BL/6J mice at the same week of age were used as control. Except for the control group, all other animals were fed with high-fat feed for 12 weeks to construct AS model, and drugs were given by gavage after successful modeling. Then, the thickness of aortic intimal hyperplasia was observed by HE staining. The total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-c) and high-density lipoprotein cholesterol (HDL-c) levels were measured by a fully-automated biochemical analyzer, and the plasma interleukin-lp(IL-Ip) and IL-18 levels were measured by ELISA. The mRNA and protein expression levels of cell apoptosis- and pyroptosis-related factors, including B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), cleaved caspase-3, nucleotide-binding oligomerization domain-like receptor protein 3(NLRP3), cleaved caspase-1 and gas dermin D・N (GSDMD-N ), were detected by immunofluorescence, RT-qPCR and Western blot assays. The combined results were used to evaluate the effect of target drugs on vascular wall cell injury in AS lesions. RESULTS: High-fat feeding induced AS model successfully. Compared with control group, the mice in model group showed increased plasma TC, TG and LDL-c levels (P<0. 01), decreased HDL-c level (P<0. 01), thickened intima (P<0. 01), increased plasma IL-lp and IL-18 levels (P<0. 01), and elevated expression levels of Bax, cleaved caspase-3, NLRP3, cleaved caspase-1 and GSDMD-N, and reduced expression of Bcl-2 in the vascular wall(PVO.01). Compared with model group, treatment with Astragalus-Angelica combination down-regulated plasma TC, TG and LDL-c levels(PV0. 05), up-regulated the plasma HDL-c level (P<0. 05), reduced the degree of intimal hyperplasia (P<0. 01), decreased plasma IL-lp and IL-18 levels (P<0. 05), inhibited the expression of Bax, cleaved caspase-3, NLRP3, cleaved caspase-1 and GSDMD-N, and promoted the expression of Bcl-2 in the vascular wall(PV0. 01). Overall, medium-dose Astragalus-Angelica exhibited the most significant effect. CONCLUSION: Combination of Astragalus and Angelica can delay the progress of AS lesions, alleviate inflammatory responses, and inhibit the apoptosis and pyrosis of vascular wall cells in mice, and its mechanism is related to the inhibition of activation of apoptosis- and pyroptosis-related factors in vascular wall cells. [ABSTRACT FROM AUTHOR]